India's Department of Pharmaceuticals (DoP) is seeking innovative technologies to reduce the cost of producing Active Pharmaceutical Ingredients (APIs) that are currently imported.
An organization has been tasked with identifying API production gaps and challenges and developing novel solutions to these challenges, reports The Pharma Letter’s India correspondent.
The Department of Pharmaceuticals is working towards creating a roadmap for India's API production ecosystem, which will outline the steps to be taken to strengthen the industry, improve competitiveness, and ensure the availability of quality APIs for domestic and global markets. The roadmap will also address the need for collaboration and cooperation among stakeholders.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze